BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29286963)

  • 1. Restricted Range of Motion and a Cold Upper Extremity in a Two-Year-Old Boy: Kaposiform Hemangioendothelioma of the Bone and the Brachial Plexus: A Case Report.
    Patel S; Kamath S; Shillingford NM; Zeinati C; Tolo V; Luu M
    JBJS Case Connect; 2017; 7(4):e79. PubMed ID: 29286963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Sirolimus in Advanced Kaposiform Hemangioendothelioma.
    Oza VS; Mamlouk MD; Hess CP; Mathes EF; Frieden IJ
    Pediatr Dermatol; 2016; 33(2):e88-92. PubMed ID: 26864138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of Kaposiform hemangioendothelioma with everolimus.
    Uno T; Ito S; Nakazawa A; Miyazaki O; Mori T; Terashima K
    Pediatr Blood Cancer; 2015 Mar; 62(3):536-8. PubMed ID: 25306933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposiform haemangioendothelioma in an adult: lack of response to topical sirolimus and response to radiotherapy.
    Der Sarkissian SA; Wong XL; Kossard S; Hong A; Sebaratnam DF
    Clin Exp Dermatol; 2022 Jan; 47(1):192-193. PubMed ID: 34480811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus therapy for kaposiform hemangioendothelioma with long-term follow-up.
    Wang Z; Yao W; Sun H; Dong K; Ma Y; Chen L; Zheng S; Li K
    J Dermatol; 2019 Nov; 46(11):956-961. PubMed ID: 31489702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased vascularization of retroperitoneal kaposiform hemangioendothelioma induced by treatment with sirolimus explains relief of symptoms.
    Iacobas I; Simon ML; Amir T; Gribbin CE; McPartland TG; Kaufman MR; Calderwood S; Nosher JL
    Clin Imaging; 2015; 39(3):529-32. PubMed ID: 25662209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
    Yao W; Li K; Wang Z; Dong K; Zheng S
    Pediatr Dermatol; 2020 Jul; 37(4):677-680. PubMed ID: 32212177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma.
    Brill R; Uller W; Huf V; Müller-Wille R; Schmid I; Pohl A; Häberle B; Perkowski S; Funke K; Till AM; Lauten M; Neumann J; Güttel C; Heid E; Ziermann F; Schmid A; Hüsemann D; Meyer L; Sporns PB; Schinner R; Schmidt VF; Ricke J; Rössler J; Kapp FG; Wohlgemuth WA; Wildgruber M
    Int J Cancer; 2021 May; 148(9):2345-2351. PubMed ID: 33231291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Refractory Mandibular Kaposiform Hemangioendothelioma with Sirolimus: A Case Report and Review of the Literature.
    Rikhotso RE; Alharbi AA
    J Oral Maxillofac Surg; 2021 Oct; 79(10):2086.e1-2086.e8. PubMed ID: 34153244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
    Wang H; Guo X; Duan Y; Zheng B; Gao Y
    Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposiform hemangioendothelioma of the bone in children and adolescents.
    Kuo C; Warren M; Malvar J; Miller JM; Shah R; Navid F; Luu M; Anselmo DM; Mascarenhas L
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29392. PubMed ID: 34606171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
    Ji Y; Chen S; Xiang B; Li K; Xu Z; Yao W; Lu G; Liu X; Xia C; Wang Q; Li Y; Wang C; Yang K; Yang G; Tang X; Xu T; Wu H
    Int J Cancer; 2017 Aug; 141(4):848-855. PubMed ID: 28486787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identical Presentation of Scapular Osteolysis in Two Patients with Thoracic Kaposiform Hemangioendothelioma.
    Alonso Arroyo V; Lopez-Gutierrez JC; Martinez R; Fernandez-Pineda I
    Pediatr Dermatol; 2017 May; 34(3):e146-e149. PubMed ID: 28382716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus Treatment of an Infant With Intrathoracic Kaposiform Hemangioendothelioma Complicated by Life-threatening Pleural and Pericardial Effusions.
    Duan L; Renzi S; Weidman D; Waespe N; Chami R; Manson D; Cada M; Carcao M
    J Pediatr Hematol Oncol; 2020 Jan; 42(1):74-78. PubMed ID: 30044355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
    Cashell J; Smink GM; Helm K; Xavier F
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case Report of 2 Sirolimus-Related Deaths Among Infants With Kaposiform Hemangioendotheliomas.
    Ying H; Qiao C; Yang X; Lin X
    Pediatrics; 2018 Apr; 141(Suppl 5):S425-S429. PubMed ID: 29610165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Intracardiac Kaposiform Hemangioendothelioma in an Infant Resolved With Sirolimus: A Case Report.
    Zaidi SJ; Shaik S; Agrawal C; Cossor W
    J Pediatr Hematol Oncol; 2018 Oct; 40(7):536-540. PubMed ID: 30067556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
    Ji Y; Chen S; Yang K; Xia C; Peng S
    J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: successful treatment with sirolimus.
    Reichel A; Hamm H; Wiegering V; Wiewrodt B; Neubauer H; Ernestus K; Winkler B
    J Dtsch Dermatol Ges; 2017 Mar; 15(3):329-331. PubMed ID: 28220608
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunohistochemical Analysis of mTOR Pathway-Related Proteins in Kaposiform Hemangioendothelioma.
    Wang Z; Zheng C; Sun H; Yao W; Li K; Ma Y; Zheng S
    Dermatology; 2020; 236(3):262-270. PubMed ID: 31896113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.